1

Spatial Genomics and Transcriptomics Market (By Technology: Spatial Transcriptomics [Sequencing-Based Methods, Microscopy-based RNA Imaging Techniques, IHC], Spatial Genomics [Microscopy-based Live DNA Imaging, FISH, Massively-Parallel Sequencing, Genome Perturbation Tools, Biochemical Techniques, Others], By Product: Instruments [By Type, By Mode], Software [Imaging Tools, Bioinformatics Tools, Storage and Management Databases, Consumable]; By End-Use: Pharmaceutical Manufacturer, Academic Customers, Translational Research, Diagnostic Customers) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format: PDF | Status: Published | Pages : 190

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Spatial Genomics and Transcriptomics
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Spatial Genomics and Transcriptomics Market By Technology
1.2.2.1. Global Spatial Genomics and Transcriptomics Market Revenue and Growth Rate Comparison By Technology (2015-2026)
1.2.2.2. Global Spatial Genomics and Transcriptomics Market Revenue Share By Technology in 2017
1.2.2.3. Spatial Transcriptomics
1.2.2.3.1. Sequencing-Based Methods
1.2.2.3.1.1. In Situ Sequencing
1.2.2.3.1.2. Laser Capture Microdissection (LCM)
1.2.2.3.1.3. Microtomy Sequencing
1.2.2.3.1.4. Transcriptome In-Vivo Analysis (TIVA)
1.2.2.3.2. Microscopy-based RNA Imaging Techniques
1.2.2.3.2.1. Padlock Probes/ Rolling Circle Amplification
1.2.2.3.2.2. Single Molecule RNA Fluorescence In-Situ Hybridization
1.2.2.3.2.3. Branched DNA Probes
1.2.2.3.3. IHC
1.2.2.4. Spatial Genomics
1.2.2.4.1. Microscopy-based Live DNA Imaging
1.2.2.4.2. FISH
1.2.2.4.3. Massively-Parallel Sequencing
1.2.2.4.4. Genome Perturbation Tools
1.2.2.4.5. Biochemical Techniques
1.2.2.4.6. Others
1.2.3. Spatial Genomics and Transcriptomics Market By Product
1.2.3.1. Global Spatial Genomics and Transcriptomics Market Revenue and Growth Rate Comparison By Product (2015-2026)
1.2.3.2. Instruments
1.2.3.2.1. By Type
1.2.3.2.1.1. IHC
1.2.3.2.1.2. Sequencing Platforms
1.2.3.2.1.3. Mass Spectrometry
1.2.3.2.1.4. Microscopy
1.2.3.2.1.5. Flow Cytometry
1.2.3.2.1.6. Others
1.2.3.2.2. By Mode
1.2.3.2.2.1. Manual
1.2.3.2.2.2. Semi-automated
1.2.3.2.2.3. Automated
1.2.3.3. Software
1.2.3.3.1. Imaging Tools
1.2.3.3.2. Bioinformatics Tools
1.2.3.3.3. Storage and Management Databases
1.2.3.4. Consumables
1.2.4. Spatial Genomics and Transcriptomics Market By End-Use
1.2.4.1. Global Spatial Genomics and Transcriptomics Market Revenue and Growth Rate Comparison By End-Use (2015-2026)
1.2.4.2. Pharmaceutical Manufacturer
1.2.4.3. Academic Customers
1.2.4.4. Translational Research
1.2.4.5. Diagnostic Customers
1.2.4.6. Others
1.2.5. Spatial Genomics and Transcriptomics Market by Geography
1.2.5.1. Global Spatial Genomics and Transcriptomics Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.5.2. North America Spatial Genomics and Transcriptomics Market Revenue and Growth Rate (2015-2026)
1.2.5.3. Europe Spatial Genomics and Transcriptomics Market Revenue and Growth Rate (2015-2026)
1.2.5.4. Asia-Pacific Spatial Genomics and Transcriptomics Market Revenue and Growth Rate (2015-2026)
1.2.5.5. Latin America Spatial Genomics and Transcriptomics Market Revenue and Growth Rate (2015-2026)
1.2.5.6. Middle East and Africa (MEA) Spatial Genomics and Transcriptomics Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Spatial Genomics and Transcriptomics Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Spatial Genomics and Transcriptomics Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Spatial Genomics and Transcriptomics Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Spatial Genomics and Transcriptomics Major Manufacturers in 2017

CHAPTER 4. SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET BY TECHNOLOGY

4.1. Global Spatial Genomics and Transcriptomics Revenue By Technology
4.2. Spatial Transcriptomics
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.2.3. Sequencing-Based Methods
4.2.3.1. In Situ Sequencing
4.2.3.2. Laser Capture Microdissection (LCM)
4.2.3.3. Microtomy Sequencing
4.2.3.4. Transcriptome In-Vivo Analysis (TIVA)
4.2.4. Microscopy-based RNA Imaging Techniques
4.2.4.1. Padlock Probes/ Rolling Circle Amplification
4.2.4.2. Single Molecule RNA Fluorescence In-Situ Hybridization
4.2.4.3. Branched DNA Probes
4.2.5. IHC
4.3. Spatial Genomics
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3.3. Microscopy-based Live DNA Imaging
4.3.4. FISH
4.3.5. Massively-Parallel Sequencing
4.3.6. Genome Perturbation Tools
4.3.7. Biochemical Techniques
4.3.8. Others

CHAPTER 5. SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET BY PRODUCT

5.1. Global Spatial Genomics and Transcriptomics Revenue By Product
5.2. Instruments
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.2.3. By Type
5.2.3.1. IHC
5.2.3.2. Sequencing Platforms
5.2.3.3. Mass Spectrometry
5.2.3.4. Microscopy
5.2.3.5. Flow Cytometry
5.2.3.6. Others
5.2.4. By Mode
5.2.4.1. Manual
5.2.4.2. Semi-automated
5.2.4.3. Automated
5.3. Software
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3.3. Imaging Tools
5.3.4. Bioinformatics Tools
5.3.5. Storage and Management Databases
5.4. Consumables
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET BY END-USE

6.1. Global Spatial Genomics and Transcriptomics Revenue By End-Use
6.2. Pharmaceutical Manufacturer
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Academic Customers
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Translational Research
6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.5. Diagnostic Customers
6.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. NORTH AMERICA SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET BY COUNTRY

7.1. North America Spatial Genomics and Transcriptomics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. North America Spatial Genomics and Transcriptomics Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. U.S.
7.3.1. U.S. Spatial Genomics and Transcriptomics Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.3.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.4.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
7.5. Mexico
7.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.5.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)

CHAPTER 8. EUROPE SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET BY COUNTRY

8.1. Europe Spatial Genomics and Transcriptomics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Europe Spatial Genomics and Transcriptomics Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.3.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.4.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.5.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.6.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.7.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)

CHAPTER 9. ASIA-PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET BY COUNTRY

9.1. Asia-Pacific Spatial Genomics and Transcriptomics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Asia-Pacific Spatial Genomics and Transcriptomics Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.3.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.4.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.5.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.6.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.7.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.8.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.8.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)

CHAPTER 10. LATIN AMERICA SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET BY COUNTRY

10.1. Latin America Spatial Genomics and Transcriptomics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Latin America Spatial Genomics and Transcriptomics Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.3.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
10.4. Argentina
10.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.4.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.5.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)

CHAPTER 11. MIDDLE EAST SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET BY COUNTRY

11.1. Middle East Spatial Genomics and Transcriptomics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Middle East Spatial Genomics and Transcriptomics Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. Saudi Arabia
11.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.3.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
11.4. UAE
11.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.4.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
11.5. Rest of Middle East
11.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.5.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)

CHAPTER 12. AFRICA SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET BY COUNTRY

12.1. Africa Spatial Genomics and Transcriptomics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Africa Spatial Genomics and Transcriptomics Market Revenue Share Comparison, 2015 & 2026 (%)
12.3. South Africa
12.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
12.3.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.3.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
12.4. Egypt
12.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
12.4.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.4.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
12.5. Rest of Africa
12.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
12.5.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.5.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)

CHAPTER 13. COMPANY PROFILE

13.1. NanoString Technologies
13.1.1. Company Snapshot
13.1.2. Overview
13.1.3. Financial Overview
13.1.4. Type Portfolio
13.1.5. Key Developments
13.1.6. Strategies
13.2. 10x Genomics
13.2.1. Company Snapshot
13.2.2. Overview
13.2.3. Financial Overview
13.2.4. Type Portfolio
13.2.5. Key Developments
13.2.6. Strategies
13.3. CARTANA AB
13.3.1. Company Snapshot
13.3.2. Overview
13.3.3. Financial Overview
13.3.4. Type Portfolio
13.3.5. Key Developments
13.3.6. Strategies
13.4. Horizon Discovery Group plc
13.4.1. Company Snapshot
13.4.2. Overview
13.4.3. Financial Overview
13.4.4. Type Portfolio
13.4.5. Key Developments
13.4.6. Strategies
13.5. Illumina, Inc.
13.5.1. Company Snapshot
13.5.2. Overview
13.5.3. Financial Overview
13.5.4. Type Portfolio
13.5.5. Key Developments
13.5.6. Strategies
13.6. S2 Genomics, Inc.
13.6.1. Company Snapshot
13.6.2. Overview
13.6.3. Financial Overview
13.6.4. Type Portfolio
13.6.5. Key Developments
13.6.6. Strategies
13.7. Dovetail Genomics
13.7.1. Company Snapshot
13.7.2. Overview
13.7.3. Financial Overview
13.7.4. Type Portfolio
13.7.5. Key Developments
13.7.6. Strategies
13.8. Seven Bridges Genomic
13.8.1. Company Snapshot
13.8.2. Overview
13.8.3. Financial Overview
13.8.4. Type Portfolio
13.8.5. Key Developments
13.8.6. Strategies
13.9. Advanced Cell Diagnostics
13.9.1. Company Snapshot
13.9.2. Overview
13.9.3. Financial Overview
13.9.4. Type Portfolio
13.9.5. Key Developments
13.9.6. Strategies
13.10. Others
13.10.1. Company Snapshot
13.10.2. Overview
13.10.3. Financial Overview
13.10.4. Type Portfolio
13.10.5. Key Developments
13.10.6. Strategies

CHAPTER 14. RESEARCH APPROACH

14.1. Research Methodology
14.1.1. Initial Data Search
14.1.2. Secondary Research
14.1.3. Primary Research
14.2. Assumptions and Scope

Cart Summary